Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 09-13-2017, 06:15 AM #1
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default Impairment of Serotonergic Transmission by L-DOPA - Mechanisms and Implications

"The interaction between L-DOPA and 5-HT transmission is especially relevant in those Parkinson's disease (PD) patients that suffer dyskinesia, comorbid anxiety or depression, since the efficacy of antidepressants or 5-HT compounds may be affected."

Frontiers | Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications | Frontiers in Cellular Neuroscience
jeffreyn is offline   Reply With QuoteReply With Quote

advertisement
Old 09-13-2017, 07:16 AM #2
anon122822
Guest
 
Posts: n/a
anon122822
Guest
 
Posts: n/a
Default

Quote:
Originally Posted by jeffreyn View Post
"The interaction between L-DOPA and 5-HT transmission is especially relevant in those Parkinson's disease (PD) patients that suffer dyskinesia, comorbid anxiety or depression, since the efficacy of antidepressants or 5-HT compounds may be affected."

Frontiers | Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications | Frontiers in Cellular Neuroscience
This is why Dr. Marty Hinz's methodology of treatment prescribes the use of 5-htp for control of Serotonin depletion through competitive inhibition at the AADC enzyme by 5-htp and L-dopa. With increasing L-dopa administration, you get less enzyme activity by 5-htp, reducing the amount of Serotonin being produced leading to less being available in the pre-synaptic vesicles and then ultimately in the synaptic cleft when post synaptic activation is required. 5-htp use in the treatment of Parkinsons disease can also control nausea, which is the main dosage limiter as patients will experience intolerable nausea once the L-dopa gets high enough which will create a dosage barrier than cannot be overcome until it is resolved. The current resolution for this issue presently is Carbidopa, but it comes with a myriad of side effects. If 5-htp is able to resolve nausea just as well, if not better, as well as preventing Serotonin depletion, leading to resolution of L-dopa side effects like depression, then it is clearly the superior option. Carbidopa also decreases the effectiveness of L-dopa as it depletes Vitamin B6 which is a co-factor in the conversion of L-dopa to Dopamine.
  Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (09-14-2017)
Old 09-15-2017, 12:04 AM #3
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

Thanks for your input billbobby21.

When you say "Carbidopa also decreases the effectiveness of L-dopa as it depletes Vitamin B6 which is a co-factor in the conversion of L-dopa to Dopamine.", you seem to be focusing on the tree and ignoring the forest.

Carbidopa can not cross the blood brain barrier (BBB). Thus, carbidopa only inhibits the enzymatic action of AADC outside of the brain, which actually INCREASES the effectiveness of L-dopa, enabling much smaller doses of L-dopa to be used. When carbidopa is not used (e.g. Hinz protocol) much larger doses of L-dopa are needed, and these large doses of L-dopa can cause nausea (unless compensated for by the use of (large doses of?) 5-HTP (and other supplements?).

The main message I get from the research paper is that the effect of L-dopa on the serotonergic system (in different parts of the brain) is quite complex, and still not fully understood.

I also noticed that this research paper makes no reference to the research papers written by Hinz et al.

Jeff
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (09-15-2017), kiwi33 (09-17-2017), Tupelo3 (09-15-2017)
Old 09-17-2017, 05:44 AM #4
kiwi33's Avatar
kiwi33 kiwi33 is offline
Grand Magnate
 
Join Date: Jan 2015
Location: Sydney, Australia.
Posts: 3,093
8 yr Member
kiwi33 kiwi33 is offline
Grand Magnate
kiwi33's Avatar
 
Join Date: Jan 2015
Location: Sydney, Australia.
Posts: 3,093
8 yr Member
Default

Thanks jeffreyn.

I think that the review is very informative - a good balance between the basic science and its potential (and important) clinical implications.
__________________
Knowledge is power.
kiwi33 is offline   Reply With QuoteReply With Quote
Old 09-18-2017, 07:26 AM #5
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

By co-incidence, Prof. Frank Church has recently written an interesting post about B vitamins (folate, B6, B12) and carbidopa/levodopa therapy.

The main message seems to be that, if you take c/l, don't overdo the vitamin B6 supplements.

B Vitamins (Folate, B6, B12) Reduce Homocysteine Levels Produced by Carbidopa/Levodopa Therapy | Journey with Parkinson's
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (09-19-2017), eds195 (09-18-2017), hercules957 (09-18-2017), kiwi33 (09-19-2017)
Reply

Tags
5-ht, anxiety, depression, l-dopa, transmission

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Implications of Breathing Dysfunction and TOS dawgilama Thoracic Outlet Syndrome 14 08-12-2016 10:44 PM
NYT article on disclosure implications Muireann Parkinson's Disease 2 07-10-2012 01:20 PM
Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and N olsen Parkinson's Disease 0 03-18-2011 07:19 PM
Depression in PD related to catecholaminergic rather than serotonergic system olsen Parkinson's Disease 10 02-12-2009 10:22 AM
Consider the possible implications reverett123 Parkinson's Disease 15 07-15-2008 01:49 PM


All times are GMT -5. The time now is 09:37 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.